Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
𝛼
SK
or Search
SIGN UP
SIGN IN
ENTITY
AK Medical Holdings Limited (1789 HK)
Watchlist
89
Analysis
Health Care
•
China
Specializes in the research, development, manufacture, and sale of artificial joint prostheses & their associated surgical instruments and applications
more
Watchlist
All
Insights
Primers
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bearish
•
Quantitative Analysis
•
01 Mar 2026 10:05
HK Connect Flows Weekly (Feb 27th): Tencent, Alibaba, Xiaomi, Meituan, Hua Hong Semiconductor
We analyzed southbound Hong Kong connect flows in the past week and highlighted flows for Tencent, Alibaba, Xiaomi, Meituan, Hua Hong...
Ke Yan, CFA, FRM
Follow
442 Views
Share
bullish
•
Quantitative Analysis
•
20 Feb 2026 10:46
Hong Kong Buybacks Weekly (Feb 20th): Xiaomi, Geely Automobile, Netease Cloud Music
We analyzed the Hong Kong buyback data in the past week and highlight the top 3 companies that repurchased the most shares were Xiaomi (1810 HK),...
Ke Yan, CFA, FRM
Follow
272 Views
Share
bullish
•
Star Sports Medicine
•
09 Dec 2025 08:55
Pre-IPO Star Sports Medicine - The Business, the Concerns and the Valuation
​STAR SPORTS leverages VBP to seize market share from foreign competitors, but facing profitability pressure in long term. Valuation would be...
Xinyao (Criss) Wang
Follow
423 Views
Share
bullish
•
Quantitative Analysis
•
07 Sep 2025 10:05
HK Connect Flows Weekly (Sep 5th): Alibaba, Ping An Insurance, Xiaomi, Tencent, Pop Mart Intl
We analyzed southbound Hong Kong connect flows in the past week and highlighted flows for Alibaba (9988 HK), Ping An Insurance (2318 HK), Xiaomi...
Ke Yan, CFA, FRM
Follow
708 Views
Share
bearish
•
Kangji Medical
•
04 Sep 2025 02:00
Kangji Medical (9997 HK): Precondition Satisfied for the Light Scheme Offer
Despite the recent derating of peers, the vote risk remains medium to high due to the imminent growth story of surgical robots, unfavourable AGM...
Arun George
Follow
545 Views
Share
First
Previous
3
4
5
6
7
8
9
Next
Last
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
How Smartkarma Compares
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4
x